VERAVAS’ proprietary nanotechnology enables the simple, efficient and cost-effective conditioning and characterization of human specimens to manage and mitigate a multitude of known sample specific interferences while also enriching low abundance biomarkers using our 6 C's:
Multiple biomarkers are easily detected and can be simultaneously analyzed in a single test.
Biomarkers are selectively released from the nano beads into the clear liquid and the nano beads are left behind.
The complex is resuspended in a smaller volume of clear liquid.
The remaining sample is washed away leaving only the complex of interest.
“Ninja” nano beads selectively capture targeted biomarkers that form a complex.
The sample is conditioned prior to the addition of nano beads for optimal biomarker binding.
Our products will both improve the sensitivity and the accuracy of existing tests for diagnostic companies, research facilities, academia, reference labs, hospitals, and even the military and direct to consumers. Here is a quick look at our initial line-up of products for 2019.
Removes multiple interference substances from patient samples including HAMA, HAAA, heterophilic interference, RF, assay specific interferences, and biotin
Removes biotin and human anti-Streptavidin interference from
Rules In/Out biotin interference from patient samples
Will target multiple biomarkers for the diagnosis of obstructive sleep apnea (OSA) in children and adults as Research Use Only (RUO) reagents
Identifies the type(s) and mechanism(s) of interference present in a sample
And coming down the pipeline we have additional products that will leverage our VERATEST platform in the near future
Potential Standard of Care to eliminate interfering substances in the collection device prior to any vendor’s diagnostic test
Urine-based test for OSA in children and adults as an alternative to sleep studies
Urine-based and blood-based tests for heart failure, acute coronary syndrome, and ultra-sensitive cardiac troponin
Blood-based test for Alzheimer’s Disease as an alternative to cerebral spinal fluid (CSF) testing
Simultaneous identification of major bacteria from whole blood without the wait for blood culture to rule in/out bacterial infection